MSD
Morgan Stanley Emerging Markets Debt Fund, Inc.stockNYSEClosed Ended Fund
At CloseOct 2, 2026 12:40:55 PM EDT
6.69USD-0.298%(-0.02)15,363
6.4500Bid7.2500Ask0.8000SpreadMSD News
MSD’s Phase IIb study of tulisokibart achieves primary endpoint ·
Clinical Trials Arena
MSD bets $2.13bn on SciBrunch’s KRAS (ON) inhibitor ·
Pharmaceutical Technology
Daiichi Sankyo, MSD withdraw cancer drug application ·
Pharmaceutical Technology
MSD’s DME drug could challenge anti-VEGF reign, late-stage study suggests ·
Clinical Trials Arena